Want to join the conversation?
$AMGN said that the US FDA has approved the Repatha (evolocumab) Pushtronex system, a new, monthly single-dose administration option. Repatha, which is a cholesterol-lowering medication, is the first and only proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor to offer a monthly single-dose delivery option.
Any idea why some investors are happy about the disastrous $UA results??
Wow! GM killed it with earnings today! Did not expect this after $F gave the feeling it will eclipse the Chevy maker completely!
Oil rebound starting to show up in energy stocks. $XOM $CVX
I have a feeling "CLOUDy" days are ahead, with $AMZN leading the pack.
$AAL is giving pay hikes to its employees but investors are sulking.